These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin. Une T, Otani T, Sato M, Ikeuchi T, Osada Y, Ogawa H, Sato K, Mitsuhashi S. Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898 [Abstract] [Full Text] [Related]
17. In vitro antibacterial activity of KP-736, a new cephem antibiotic. Maejima T, Inoue M, Mitsuhashi S. Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964 [Abstract] [Full Text] [Related]
18. Mode of action of the dual-action cephalosporin Ro 23-9424. Georgopapadakou NH, Bertasso A, Chan KK, Chapman JS, Cleeland R, Cummings LM, Dix BA, Keith DD. Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755 [Abstract] [Full Text] [Related]
19. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Entenza JM, Hohl P, Heinze-Krauss I, Glauser MP, Moreillon P. Antimicrob Agents Chemother; 2002 Jan; 46(1):171-7. PubMed ID: 11751129 [Abstract] [Full Text] [Related]
20. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams. Watanabe Y, Minami S, Hayashi T, Araki H, Kitayama R, Ochiai H. Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]